electroCore Stock (NASDAQ:ECOR)
Previous Close
$7.75
52W Range
$4.46 - $19.49
50D Avg
$5.90
200D Avg
$10.24
Market Cap
$53.68M
Avg Vol (3M)
$123.26K
Beta
0.80
Div Yield
-
ECOR Company Profile
electroCore, Inc., a commercial stage medical device company, engages in the development and commercialization of a range of non-invasive vagus nerve stimulation (nVNS) therapies. The company is developing gammaCore, a prescription-only nVNS therapy for the acute treatment of pain associated with migraine and episodic cluster headache in adults. Its lead product is gammaCore Sapphire, a rechargeable and reloadable handheld device for regular or intermittent use over many years. The company was incorporated in 2005 and is headquartered in Rockaway, New Jersey.
ECOR Performance
Revenue Breakdown
Revenue Breakdown by Product/Service
Quarter
| Product/Service | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| UNITED STATES | $3.13M | $2.37M | $2.13M | $1.56M | $1.69M | $1.59M | $1.13M | $1.10M | - | - | - | - |
| JAPAN | $18.00K | $46.00K | $46.00K | $45.00K | $48.00K | - | - | - | - | - | - | - |
| Other Countries | $22.00K | - | - | - | - | - | - | - | - | - | - | - |
| Other | - | $43.00K | $55.00K | $25.00K | $64.00K | $39.00K | $26.02K | $16.52K | $32.94K | $62.88K | $8.98K | $1.73K |
| Americas | - | - | - | - | - | - | - | - | $882.57K | $823.98K | $800.77K | - |
| Europe | - | - | - | - | - | - | - | - | - | $316.99K | $278.34K | - |
Latest
Fiscal year ends in Dec 24 | Currency in USD